CIK 0000885590 · Large accelerated filer
Bausch Health Companies Inc.
Sign in to watch- Ticker
- BHC
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NJ
- Entity type
- operating
- Phone
- 514-744-6792
- Business address
- 2150 ST. ELZEAR BLVD. WEST, LAVAL, QUEBEC, Quebec, Canada, H7L 4A8
- Former names
- Valeant Pharmaceuticals International, Inc., BIOVAIL Corp, BIOVAIL CORP INTERNATIONAL, BIOVAIL CORPORATION INTERNATIONAL
- 4 Grant or award Director acquired 3,684 shares (grant or award)
- 4 Grant or award Director acquired 3,642 shares (grant or award)
- 4/A Open-market sale EVP, General Counsel sold 1,275 shares at an average $9.27 ($11,824)
- 4 Shares withheld for taxes EVP, General Counsel gave up 11,069 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 27,607 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Chief Financial Officer gave up 4,001 shares (to pay taxes)
- 4 Grant or award SVP, Controller & CAO acquired 25,266 shares (grant or award)
- 144 Insider Sale of Securities
- 4 Open-market sale EVP, General Counsel sold 292 shares at $9.32 ($2,721)
- 4 Shares withheld for taxes Chief Executive Officer gave up 6,327 shares (to pay taxes)
- 8-K Event Executive or director change · Regulation FD disclosure
- 10-K Report Annual Report
- 8-K Event Results of operations
- 8-K Event Regulation FD disclosure
- SC 13G Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 4 Shares withheld for taxes EVP, Chief Financial Officer gave up 6,310 shares (to pay taxes)
- 4 Grant or award Director acquired 5,186 shares (grant or award)
- 4 Grant or award Director acquired 4,589 shares (grant or award)
Page 15 of 121 · 2,419 filings